Antibodies to Malaria Vaccine Candidates Pvs25 and Pvs28 Completely Block the Ability of Plasmodium vivax To Infect Mosquitoes

Transmission-blocking vaccines are one strategy for controlling malaria, whereby sexual-stage parasites are inhibited from infecting mosquitoes by human antibodies. To evaluate whether the recently cloned Plasmodium vivax proteins Pvs25 and Pvs28 are candidates for a transmission-blocking vaccine, t...

Descripció completa

Dades bibliogràfiques

Publicat a:	Infect Immun
Autors principals:	Hisaeda, Hajime, Stowers, Anthony W., Tsuboi, Takafumi, Collins, William E., Sattabongkot, Jetsumon S., Suwanabun, Natavadee, Torii, Motomi, Kaslow, David C.
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology (ASM) 2000
Matèries:	Fungal and Parasitic Infections
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC97758/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11083773/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.68.12.6618-6623.2000
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!